Future cardiovascular disease in china: markov model and risk factor scenario projections from the coronary heart disease policy model-china.
about
In-home solid fuel use and cardiovascular disease: a cross-sectional analysis of the Shanghai Putuo studyEpidemiology and prevention of stroke: a worldwide perspectivePolymorphisms in Telomere Length Associated TERC and TERT predispose for Ischemic Stroke in a Chinese Han populationHousehold Solid Fuel Use and Cardiovascular Disease in Rural Areas in Shanxi, ChinaCharacteristics of high risk people with cardiovascular disease in Chinese rural areas: clinical indictors, disease patterns and drug treatmentThe Cost-Effectiveness of Low-Cost Essential Antihypertensive Medicines for Hypertension Control in China: A Modelling StudyThe emerging role of outdoor and indoor air pollution in cardiovascular diseaseIs prevention a fantasy, or the future of medicine? A panoramic view of recent data, status, and direction in cardiovascular prevention.Heat-related mortality projections for cardiovascular and respiratory disease under the changing climate in Beijing, China.The Associations Between Retirement and Cardiovascular Disease Risk Factors in China: A 20-Year Prospective Study.Cardiovascular disease risk reduction in rural China: a clustered randomized controlled trial in ZhejiangImpact on cardiovascular disease events of the implementation of Argentina's national tobacco control law.Modeling the Burden of Cardiovascular Diseases in Iran from 2005 to 2025: The Impact of Demographic ChangesThe China Patient-Centered Evaluative Assessment of Cardiac Events (China PEACE) retrospective study of acute myocardial infarction: study design.Coronary Catheterization and Percutaneous Coronary Intervention in China: 10-Year Results From the China PEACE-Retrospective CathPCI Study.Novel adjunctive treatments of myocardial infarction.Efficacy, safety and tolerability of ongoing statin plus ezetimibe versus doubling the ongoing statin dose in hypercholesterolemic Taiwanese patients: an open-label, randomized clinical trialCost-effectiveness of optimal use of acute myocardial infarction treatments and impact on coronary heart disease mortality in China.Potential Impact of Time Trend of Life-Style Factors on Cardiovascular Disease Burden in China.Age-period-cohort projections of ischaemic heart disease mortality by socio-economic position in a rapidly transitioning Chinese populationProjected impact of a sodium consumption reduction initiative in Argentina: an analysis from the CVD policy model--Argentina.A medical costs study of older patients with acute myocardial infarction and metabolic syndrome in hospital.Comparison of predictive value of cardiometabolic indices for subclinical atherosclerosis in Chinese adults.National trends in hospital length of stay for acute myocardial infarction in China.The emerging epidemic of obesity, diabetes, and the metabolic syndrome in chinaTrends in cardiac biomarker testing in China for patients with acute myocardial infarction, 2001 to 2011: China PEACE-retrospective AMI studyGoal attainments and their discrepancies for low density lipoprotein cholesterol (LDL-C) and apolipoprotein B (apo B) in over 2,000 Chinese patients with known coronary artery disease or type 2 diabetesVisible Thrombolysis Acceleration of a Nanomachine Powered by Light-Driving F0F1-ATPase Motor.Expression of circulating miR-486 and miR-150 in patients with acute myocardial infarction.Salt reduction and hypertension in China: a concise state-of-the-art review.Serum lipids and associated factors of dyslipidemia in the adult population in Shenzhen.Changes in stroke epidemiology, prevention, and treatment.Short-Term and Long-Term Survival After Revascularization with or without Mitral Valve Surgery of Patients with Ischemic Mitral Valve Regurgitation: A Meta-Analysis.The High Prevalence of Low HDL-Cholesterol Levels and Dyslipidemia in Rural Populations in Northwestern China.Elevated Total Homocysteine Levels in Acute Ischemic Stroke Are Associated With Long-Term MortalityEstimating the future burden of cardiovascular disease and the value of lipid and blood pressure control therapies in China.Glycemic and blood pressure control in older patients with hypertension and diabetes: association with carotid atherosclerosisTreatment of dyslipidemia in the elderly.Urban and Rural Differences of Acute Cardiovascular Disease Events: A Study from the Population-Based Real-Time Surveillance System in Zhejiang, China in 2012.Clinical pathways based on integrative medicine in chinese hospitals improve treatment outcomes for patients with acute myocardial infarction: a multicentre, nonrandomized historically controlled trial.
P2860
Q23918202-5BBC510F-8E64-417B-9482-1FF64FD2E51FQ26824870-946AD67A-C676-49DE-BC46-7C952CD20BE2Q28359746-531B19ED-0247-43E3-8F53-A901FD70BEA5Q28385831-40D39087-7283-43ED-8875-6DCAF9C8EB3BQ28485196-BE640DAC-1346-40B1-A293-B1B8CF6C0A47Q28546995-019B1E47-E3F6-4A08-923C-7DEAB34E7E7BQ28678689-E7456546-FDA5-469F-AD68-3A67814C0DB0Q30397875-277B4352-86A4-412C-97B8-325613EFDE66Q30985499-F36E29DD-BE96-442C-B7B2-C2F02D7CE5B3Q33571917-7491F8AE-14AE-445B-873E-4BB49D4C795BQ33588766-7C2CA38D-19A7-407F-8EC6-914F6908C085Q33632321-153D7063-1A9F-42C6-BF23-A0387E2FC62EQ33711082-15083B6B-CA33-4AEE-AC11-16CC462FEB4FQ33745054-A3FCF9E0-8F3E-4292-A5B7-1BC0F246A2C7Q33764449-8FD897B2-9CB3-4804-BB24-A855B9AE0819Q33812924-A9271EFD-94AF-4ABE-B8AF-29BC8AF42266Q34279028-10562BDC-2C7C-40FE-8654-7E88C54515DBQ34313975-D6DB3925-E9BD-4DD6-9DD3-75303A017C62Q34537831-668CF060-851D-4E22-9087-86C070CCA6D2Q34674986-07C553F1-A8A3-4BA7-A528-60E2A4EC3969Q34989374-5EB46ED1-1831-4E5B-ACAC-2DD25D696A49Q35043784-B63C30EC-EDEB-4A9E-BDA0-345E99F6351BQ35137575-51BD4858-D2E8-4350-B549-7EE707524B98Q35180304-347897C4-A3D3-489B-8412-C30228817227Q35231814-CD8E8286-593E-4B2F-B556-EB109A008E68Q35500471-81B2F4A9-7FE8-4169-8EFE-1E9083E26DCBQ35572154-0DD24327-7C41-4173-AB08-A8A0A93BEC4CQ35661594-4734E420-73F5-42B0-B565-CF4643C8D695Q35664601-4EFC2226-9BD8-40BC-9200-B2E2F7679B5AQ35671783-6A741C87-DB90-4DC0-81E4-41A403B86EBDQ35848122-D759F9E9-E7AD-478D-A280-4415BB264E93Q35850235-2E92AC3D-AF60-4853-92F9-D2EDCF27803FQ35860572-6A0F1A3B-5D01-4937-99AC-C648AEB9BBFAQ35861948-BBFBD2D3-FC1F-4577-A2AA-4E9B925004D5Q35974310-A3597152-5D4F-4AF6-926B-3C74B1A2A1AFQ36013827-5EFDFF64-F23D-448D-8A3D-11267DCCA490Q36077204-3E01EBBE-593F-487E-90E3-AE1B22F428A5Q36077229-CD09A473-8E58-414B-A246-A455D9F3A14AQ36179392-917B19B2-BCE8-4C55-8EB2-383B692F0A81Q36256748-57BBEBBB-4BAA-4387-9D90-BAB3F9DB033B
P2860
Future cardiovascular disease in china: markov model and risk factor scenario projections from the coronary heart disease policy model-china.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Future cardiovascular disease ...... rt disease policy model-china.
@ast
Future cardiovascular disease ...... rt disease policy model-china.
@en
Future cardiovascular disease ...... rt disease policy model-china.
@nl
type
label
Future cardiovascular disease ...... rt disease policy model-china.
@ast
Future cardiovascular disease ...... rt disease policy model-china.
@en
Future cardiovascular disease ...... rt disease policy model-china.
@nl
prefLabel
Future cardiovascular disease ...... rt disease policy model-china.
@ast
Future cardiovascular disease ...... rt disease policy model-china.
@en
Future cardiovascular disease ...... rt disease policy model-china.
@nl
P2093
P2860
P1476
Future cardiovascular disease ...... rt disease policy model-china.
@en
P2093
Andrew Moran
Chung-Shiuan Chen
Dongfeng Gu
Lee Goldman
Pamela Coxson
Y Claire Wang
P2860
P304
P356
10.1161/CIRCOUTCOMES.109.910711
P577
2010-05-04T00:00:00Z